Associated Papers
Whole-Exome Sequencing Reveals High Prevalence of Germline Alterations in Neuroendocrine Neoplasms.
Sukrithan V et al.
Journal of the National Comprehensive Cancer Network : Jnccn, 2025
40588228 (PubMed )
Supplement: jnccn240295SupplementaryData1.pdf
Alternative splicing generates isoform diversity in MEN1.
Ramachandran A et al.
Endocrine Oncology (bristol, England), 2024
39649118 (PubMed )
Supplement: supplementary_table_3.xlsx › Supplementary_Table_3
Clinical and molecular characterization of parathyroid carcinoma in multiple endocrine neoplasia type 1.
Lomelino Pinheiro S et al.
Endocrine Connections, 2023
Expressions of Cushing's syndrome in multiple endocrine neoplasia type 1.
Simonds WF
Frontiers in Endocrinology, 2023
Observational study of population genomic screening for variants associated with endocrine tumor syndromes in a large, healthcare-based cohort.
Savatt JM et al.
Bmc Medicine, 2022
Two distinct classes of thymic tumors in patients with MEN1 show LOH at the MEN1 locus.
Mandl A et al.
Endocrine-related Cancer, 2021
ONCOGENE PANEL SEQUENCING ANALYSIS IDENTIFIES CANDIDATE ACTIONABLE GENES IN ADVANCED WELL-DIFFERENTIATED GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS.
Tirosh A et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2019
Children with MEN1 gene mutations may present first (and at a young age) with Cushing disease.
Makri A et al.
Clinical Endocrinology, 2018
Gonadotroph tumor associated with multiple endocrine neoplasia type 1.
Benito M et al.
The Journal of Clinical Endocrinology and Metabolism, 2005
Clinical genetic testing and early surgical intervention in patients with multiple endocrine neoplasia type 1 (MEN 1).
Lairmore TC et al.
Annals of Surgery, 2004
Select a paper to view details